Articles
What Are IDEAs Made Of: Market access

What Are IDEAs Made Of: Market access

Who better to round off this week’s focus on market access than Mike Rea, with the WAIMO perspective on what pharma is or isn’t doing right! Oddly, pharma is the only industry that seems to feel the need to give 'making sure our customers can buy our products' a special name...

Articles
Market access challenges driving pharma change

Market access challenges driving pharma change

Taking a helicopter view of the market access landscape, Arnault Billy assesses how the current challenges are driving the development of innovative new pharma tools. As part of the research into our recent white paper on market access (published with Capgemini Consulting) we saw that…

Articles
Historic change reduces access to innovation

Historic change reduces access to innovation

As Obama passes the historic and controversial healthcare reform bill, Erroin A. Martin asks what impact this will have on market access and medicine availability in the US. The passage of comprehensive healthcare reform in the United States begins a new chapter for the pharmaceutical industry…

Sales & Marketing

Sales & Marketing
Solution Spotlight: BrandPRO Biopharma
Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Digital

Market Access

Editor's Picks

  1. UK budget includes £1bn biopharma investment package
  2. HHS doubles down on controversial peptides plan
  3. Lilly's triple G overpowers Ozempic in diabetes trial
  4. UK puts £100m into "world-first" AI biosecurity facility
  5. US gives $99m for Ebola jab project, as cases spread in Africa

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more